Opus Genetics, Inc
Price
FilingsNewest: 8-K, Regulation FD disclosureSep 11 →Insiders1 insider bought $323,890 in 2 open-market buys. 8 insiders sold $16.4M, 0 of 12 sales on a 10b5-1 plan.→HoldersNantahala 7.4%Caligan Partners 7.4%Adage Capital Partners GP 7.3%→Financing →PeersClosest companies: DYN, RARE, ERAS→
From the filings
Figures
- Revenue
- $9.9Mlast 12 months
- Net income
- −$107.6Mlast 12 months
- Operating cash flow
- −$39.0Mlast 12 months
- Cash and equivalents
- $88.8Mat the last balance sheet
- Total debt
- $35.3Mat the last balance sheet
- Shares outstanding
- 82.6M shareson issue